Clinical Trial Update: Esomeprazole for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating esomeprazole for relief of NSAID-associated upper gastrointestinal symptoms in GERD patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Esomeprazole (Esomeprazole)

Snippet

Sponsor: AstraZeneca | Conditions: GERD | Phase 3 | Status: COMPLETED